JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

10.95 3.99

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.73

Max

10.95

Chiffres clés

By Trading Economics

Revenu

3.7M

-1.7M

Ventes

33M

435M

Marge bénéficiaire

-0.392

Employés

4,427

EBITDA

12M

66M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

+0.46% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-83M

833M

Ouverture précédente

6.96

Clôture précédente

10.95

Sentiment de l'Actualité

By Acuity

50%

50%

155 / 347 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 mai 2026, 23:47 UTC

Résultats

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3 mai 2026, 22:35 UTC

Résultats

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3 mai 2026, 23:39 UTC

Market Talk

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3 mai 2026, 23:34 UTC

Market Talk

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3 mai 2026, 23:32 UTC

Résultats

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3 mai 2026, 23:30 UTC

Market Talk

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3 mai 2026, 23:20 UTC

Market Talk

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3 mai 2026, 23:16 UTC

Acquisitions, Fusions, Rachats

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3 mai 2026, 22:45 UTC

Market Talk

Global Equities Roundup: Market Talk

3 mai 2026, 22:45 UTC

Market Talk

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3 mai 2026, 22:20 UTC

Résultats

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3 mai 2026, 22:08 UTC

Résultats

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3 mai 2026, 22:05 UTC

Résultats

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3 mai 2026, 22:05 UTC

Résultats

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3 mai 2026, 22:05 UTC

Résultats

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3 mai 2026, 22:04 UTC

Résultats

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3 mai 2026, 22:03 UTC

Résultats

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3 mai 2026, 22:03 UTC

Résultats

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3 mai 2026, 22:02 UTC

Résultats

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3 mai 2026, 22:02 UTC

Résultats

NAB 1H Cash Earnings A$2.64B>NAB.AU

3 mai 2026, 22:02 UTC

Résultats

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3 mai 2026, 22:01 UTC

Résultats

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3 mai 2026, 22:01 UTC

Résultats

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3 mai 2026, 22:01 UTC

Résultats

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3 mai 2026, 15:06 UTC

Résultats

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

0.46% hausse

Prévisions sur 12 Mois

Moyen 11 USD  0.46%

Haut 12 USD

Bas 9 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

6 ratings

0

Achat

4

Maintien

2

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

155 / 347Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat